Prognostic impact of the distance from the anterior surface to tumor cells in pancreatoduodenectomy with neoadjuvant chemoradiotherapy for pancreatic ductal adenocarcinoma
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0307876 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Miki Usui und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncologic Pathology, Mie University Graduate School of Medicine, Tsu, Mie, Japan. Hauptthemen laut MEDLINE: Pancreaticoduodenectomy, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Neoadjuvant Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Several reports have shown the importance of margins in pancreatoduodenectomy (PD) specimens; however, whether anterior surfaces are included as margins varies among reports. In this study, we aimed to examine the impact of the anterior surface on disease-free survival (DFS) and overall survival (OS).
Method
In total, 98 patients who underwent PD after chemoradiotherapy for pancreatic ductal adenocarcinoma at Mie University Hospital between January 1, 2012, and December 31, 2019, were included. We investigated the prognostic impact of the distance from the anterior surface to tumor cells on DFS and OS using a log-rank test. Multivariate analysis was performed using Cox proportional hazards analysis.
Results
A significant difference in DFS and OS was observed up to a distance of 5 mm from the anterior surface of tumor cells. The multivariate analysis revealed that the distance from the anterior surface to tumor cells (≤5 mm) was an independent poor prognostic factor for DFS and OS.
Conclusion
In patients with PD treated with neoadjuvant therapy, the distance from the anterior surface to tumor cells is an important assessment and should be included in the pathology report.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Oncologic Pathology, Mie University Graduate School of Medicine, Tsu, Mie, Japan.
- Department of Pathology, Kansai Medical University, Hirakata, Osaka, Japan.
- Department of Hepato-Biliary-Pancreatic and Transplant Surgery, Mie University School of Medicine, Tsu, Mie, Japan.
ORCID-Profile: Miki Usui, Katsunori Uchida, Shugo Mizuno
Zitieren
APA
Usui, M., Uchida, K., Hayasaki, A., Kishiwada, M., Mizuno, S., & Watanabe, M. (2024). Prognostic impact of the distance from the anterior surface to tumor cells in pancreatoduodenectomy with neoadjuvant chemoradiotherapy for pancreatic ductal adenocarcinoma. PLOS ONE. https://doi.org/10.1371/journal.pone.0307876
Vancouver
Usui M, Uchida K, Hayasaki A, Kishiwada M, Mizuno S, Watanabe M. Prognostic impact of the distance from the anterior surface to tumor cells in pancreatoduodenectomy with neoadjuvant chemoradiotherapy for pancreatic ductal adenocarcinoma. PLOS ONE. 2024. doi:10.1371/journal.pone.0307876
BibTeX
@article{Usui2024,
author = {Usui, Miki and Uchida, Katsunori and Hayasaki, Aoi and Kishiwada, Masashi and Mizuno, Shugo and Watanabe, Masatoshi},
title = {Prognostic impact of the distance from the anterior surface to tumor cells in pancreatoduodenectomy with neoadjuvant chemoradiotherapy for pancreatic ductal adenocarcinoma},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0307876}
}
EUVIMED